326 related articles for article (PubMed ID: 20453532)
1. Lithium: still a cornerstone in the long-term treatment in bipolar disorder?
Nivoli AM; Murru A; Vieta E
Neuropsychobiology; 2010; 62(1):27-35. PubMed ID: 20453532
[TBL] [Abstract][Full Text] [Related]
2. The cost-effectiveness of lamotrigine in the maintenance treatment of adults with bipolar I disorder.
Calvert NW; Burch SP; Fu AZ; Reeves P; Thompson TR
J Manag Care Pharm; 2006 May; 12(4):322-30. PubMed ID: 16792438
[TBL] [Abstract][Full Text] [Related]
3. Anticonvulsants in bipolar disorder.
Singh V; Muzina DJ; Calabrese JR
Psychiatr Clin North Am; 2005 Jun; 28(2):301-23. PubMed ID: 15826734
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.
Smith LA; Cornelius V; Warnock A; Bell A; Young AH
Bipolar Disord; 2007 Jun; 9(4):394-412. PubMed ID: 17547586
[TBL] [Abstract][Full Text] [Related]
5. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
Yatham LN
J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.
van der Loos ML; Mulder P; Hartong EG; Blom MB; Vergouwen AC; van Noorden MS; Timmermans MA; Vieta E; Nolen WA;
Bipolar Disord; 2011 Feb; 13(1):111-7. PubMed ID: 21320258
[TBL] [Abstract][Full Text] [Related]
7. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
[TBL] [Abstract][Full Text] [Related]
8. The pharmacological treatment of bipolar disorder: the question of modern advances.
Hirschowitz J; Kolevzon A; Garakani A
Harv Rev Psychiatry; 2010; 18(5):266-78. PubMed ID: 20825264
[TBL] [Abstract][Full Text] [Related]
9. Maintenance therapies in bipolar disorder: focus on randomized controlled trials.
Muzina DJ; Calabrese JR
Aust N Z J Psychiatry; 2005 Aug; 39(8):652-61. PubMed ID: 16050919
[TBL] [Abstract][Full Text] [Related]
10. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
11. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
[TBL] [Abstract][Full Text] [Related]
12. Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials.
Suppes T; Vieta E; Gustafsson U; Ekholm B
Depress Anxiety; 2013 Nov; 30(11):1089-98. PubMed ID: 23761037
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania.
Amrollahi Z; Rezaei F; Salehi B; Modabbernia AH; Maroufi A; Esfandiari GR; Naderi M; Ghebleh F; Ahmadi-Abhari SA; Sadeghi M; Tabrizi M; Akhondzadeh S
J Affect Disord; 2011 Mar; 129(1-3):327-31. PubMed ID: 20843556
[TBL] [Abstract][Full Text] [Related]
14. Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6).
Licht RW; Nielsen JN; Gram LF; Vestergaard P; Bendz H
Bipolar Disord; 2010 Aug; 12(5):483-93. PubMed ID: 20712749
[TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotics for bipolar disorder.
Yatham LN
Psychiatr Clin North Am; 2005 Jun; 28(2):325-47. PubMed ID: 15826735
[TBL] [Abstract][Full Text] [Related]
16. Evolving trends in the long-term treatment of bipolar disorder.
Vieta E; Rosa AR
World J Biol Psychiatry; 2007; 8(1):4-11. PubMed ID: 17366344
[TBL] [Abstract][Full Text] [Related]
17. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.
Goodwin FK
J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480
[TBL] [Abstract][Full Text] [Related]
18. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15-year register-based follow-up.
Licht RW; Vestergaard P; Brodersen A
Bipolar Disord; 2008 Feb; 10(1):79-86. PubMed ID: 18199244
[TBL] [Abstract][Full Text] [Related]
20. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
